Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy

Cancer Gene Therapy

Volumn 19, Issue 5, 2012, Pages 352-357

  Noyan, F ^a   Diez I A ^a,b   Hapke, M ^a   Klein, C ^a   Dewey, R A ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

Author keywords

HSP70B promoter; self inactivating lentiviral vectors; TbRIIDN; TGF beta receptor II dominant negative mutant

Indexed keywords

LENTIVIRUS VECTOR; RECOMBINANT PROTEIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION REGULATION; GENE THERAPY; GLIOMA; GLIOMA CELL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL; TREATMENT RESISTANT DEPRESSION;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GENE THERAPY; GLIOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LENTIVIRUS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSGENES;

MUS;

EID: 84859915248     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2012.8     Document Type: Article

References (32)

1. Gervois N, Guilloux Y, Diez E, Jotereau F. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J Exp Med 1996; 183: 2403-2407. (Pubitemid 26158935)
2. Restifo NP. Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nat Med 2000; 6: 493-495. (Pubitemid 30305889)
3. Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 2007; 9: 1000-1004. (Pubitemid 47338137)
4. Anderson PM, Katsanis E, Leonard AS, Schow D, Loeffler CM, Goldstein MB et al. Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastases. Cancer Res 1990; 50: 1853-1856. (Pubitemid 20098833)
5. Vaage J. Peri-tumor interleukin-2 causes systemic therapeutic effect via interferon-gamma induction. Int J Cancer 1991; 49: 598-600.
6. White RL, Schwartzentruber DJ, Guleria A, MacFarlane MP, White DE, Tucker E et al. Cardiopulmonary toxicity of treatment with high dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal cell carcinoma. Cancer 1994; 74: 3212-3222. (Pubitemid 24375079)
7. Havell EA, Fiers W, North RJ. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med 1988; 167: 1067-1085.
8. Anton M, Gomaa IE, von Lukowicz T, Molls M, Gansbacher B, Würschmidt F. Optimization of radiation controlled gene expression by adenoviral vectors in vitro. Cancer Gene Ther 2005; 7: 640-646. (Pubitemid 40967224)
9. Loew R, Heinz N, Hampf M, Bujard H, Gossen M. Improved Tet-responsive promoters with minimized background expression. BMC Biotechnol 2010; 10: 81.
10. Chyung YH, Peng PD, Kay MA. System for simultaneous tissue-specific and disease-specific regulation of therapeutic gene expression. Hum Gene Ther 2003; 14: 1255-1264. (Pubitemid 37034575)
11. Frecha C, Szécsi J, Cosset FL, Verhoeyen E. Strategies for targeting lentiviral vectors. Curr Gene Ther 2008; 8: 449-460.
12. Shah AH, Tabayoyong WB, Kundu SD, Kim SJ, Van Parijs L, Liu VC et al. Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice. Cancer Res 2002; 62: 7135-7138. (Pubitemid 36025224)
13. Gorelik L, Flavell RA. Abrogation of TGF beta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000; 12: 171-181. (Pubitemid 30398631)
14. Shah AH, Tabayoyong WB, Kimm SY, Kim SJ, Van Parijs L, Lee C. Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptortransduced bone marrow leads to myeloid expansion and inflammatory disease. J Immunol 2002; 169: 3485-3491.
15. Borrelli MJ, Schoenherr DM, Wong A, Bernock LJ, Corry PM. Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res 2001; 61: 1113-1121. (Pubitemid 32174433)
16. Li GC, He F, Shao X, Urano M, Shen L, Kim D et al. Adenovirus-mediated heatactivated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Cancer Res 2003; 63: 3268-3274. (Pubitemid 36735882)
17. Vekris A, Maurange C, Moonen C, Mazurier F, De Verneuil H, Canioni P et al. Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter. J Gene Med 2000; 2: 89-96.
18. Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K et al. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 2003; 94: 308-313. (Pubitemid 36575900)
19. Liu Y, Kon T, Li C, Zhong P. High intensity focused ultrasound-induced gene activation in solid tumors. J Acoust Soc Am 2006; 120: 492-501. (Pubitemid 44014187)
20. Schambach A, Bohne J, Chandra S, Will E, Margison GP, Williams DA et al. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther 2006; 13: 391-400. (Pubitemid 43056905)
21. Gerner EW, Hersh EM, Pennington M, Tsang TC, Harris D, Vasanwala F et al. Heat-inducible vectors for use in gene therapy. Int J Hyperthermia 2000; 16:171-181. (Pubitemid 30179150)
22. Huang Q, Hu JK, Lohr F, Zhang L, Braun R, Lanzen J et al. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 2000; 60:3435-3439. (Pubitemid 30482161)
23. Smith RC, Machluf M, Bromley P, Atala A, Walsh K. Spatial and temporal control of transgene expression through ultrasound-mediated induction of the heat shock protein 70B promoter in vivo. Hum Gene Ther 2002; 13: 697-706. (Pubitemid 34280484)
24. Xu L, Zhao Y, Zhang Q, Li Y, Xu Y. Regulation of transgene expression in muscles by ultrasound-mediated hyperthermia. Gene Ther 2004; 11: 894-900. (Pubitemid 38786603)
25. Silcox CE, Smith RC, King R, McDannold N, Bromley P, Walsh K et al. MRI-guided ultrasonic heating allows spatial control of exogenous luciferase in canine prostate. Ultrasound Med Biol 2005; 31: 965-970. (Pubitemid 40828635)
26. Plathow C, Lohr F, Divkovic G, Rademaker G, Farhan N, Peschke P et al. Focal gene induction in the liver of rats by a heat-inducible promoter using focused ultrasound hyperthermia: preliminary results. Invest Radiol 2005; 40: 729-735. (Pubitemid 41546840)
27. Mahadevan NR, Maurizio Z. Tumor stress inside out: cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment. J Immunol 2011; 187: 4403-4409.
28. Wojtowicz-Praga S. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 1997; 20: 165-177. (Pubitemid 28011544)
29. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998; 95:3908-3913. (Pubitemid 28173227)
30. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002; 62: 3603-3608. (Pubitemid 34728832)
31. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 2003; 9: 789-795. (Pubitemid 36749231)
32. Li ZY, Liu Y, Tuve S, Xun Y, Fan X, Min L et al. Toward a stem cell gene therapy for breast cancer. Blood 2009; 113: 5423-5433.